Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Prieto-Alhambra"'
Autor:
Mees Mosseveld, Albert Prats-Uribe, Paras P. Mehta, Talita Duarte-Salles, James Weaver, H Morgan-Stewart, Sajan Khosla, Kristine E. Lynch, Kristin Kostka, Michael E. Matheny, George Hripcsak, Christian G. Reich, Gowtham A. Rao, Maria Tereza Fernandes Abrahão, Sergio Fernandez-Bertolin, Daniel Prieto-Alhambra, Patricia Biedermann, Fredrik Nyberg, Aedín C. Culhane, Haini Wen, Matthew E. Spotnitz, David Vizcaya, Osaid Alser, Thamir M. Alshammari, Danielle Newby, Laura Hester, Junqing Xie, Martijn J. Schuemie, Jill Hardin, Johan van der Lei, Mitchell M. Conover, Heba Alghoul, Peter R. Rijnbeek, Jennifer C E Lane, Sarah Seager, Alexander Davydov, Rae Woong Park, Christophe G. Lambert, Azza Shoaibi, Marc A. Suchard, Daniel R. Morales, Andrea V. Margulis, Selva Muthu Kumaran Sathappan, Marcel de Wilde, Lin Zhang, Oleg Zhuk, Seamus Kent, Jenna Reps, Spyros Kolovos, Juan M. Banda, Edward Burn, Anthony G. Sena, Benjamin Skov Kaas-Hansen, Patrick B. Ryan, Kristina Fišter, Seng Chan You, Anna Ostropolets, Dmitry Dymshyts, Rupa Makadia, Carmine O. Torre, Paula Casajust, Scott L. DuVall
Publikováno v:
The Lancet Rheumatology, 2(11), E698-E711. Lancet Publishing Group
The Lancet Rheumatology
Lane, J C E, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, M T F, Alghoul, H, Alser, O, Alshammari, T M, Biedermann, P, Banda, J M, Burn, E, Casajust, P, Conover, M M, Culhane, A C, Davydov, A, DuVall, S L, Dymshyts, D, Fernandez-Bertolin, S, Fišter, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, B S, Kent, S, Khosla, S, Kolovos, S, Lambert, C G, van der Lei, J, Lynch, K E, Makadia, R, Margulis, A V, Matheny, M E, Mehta, P, Morales, D R, Morgan-Stewart, H, Mosseveld, M, Newby, D, Nyberg, F, Ostropolets, A, Park, R W, Prats-Uribe, A, Rao, G A, Reich, C, Reps, J, Rijnbeek, P, Sathappan, S M K, Schuemie, M, Seager, S, Sena, A G, Shoaibi, A & OHDSI-COVID-19 consortium 2020, ' Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis : a multinational, retrospective study ', The Lancet Rheumatology, vol. 2, no. 11, pp. e698-e711 . https://doi.org/10.1016/S2665-9913(20)30276-9
The Lancet Rheumatology
Lane, J C E, Weaver, J, Kostka, K, Duarte-Salles, T, Abrahao, M T F, Alghoul, H, Alser, O, Alshammari, T M, Biedermann, P, Banda, J M, Burn, E, Casajust, P, Conover, M M, Culhane, A C, Davydov, A, DuVall, S L, Dymshyts, D, Fernandez-Bertolin, S, Fišter, K, Hardin, J, Hester, L, Hripcsak, G, Kaas-Hansen, B S, Kent, S, Khosla, S, Kolovos, S, Lambert, C G, van der Lei, J, Lynch, K E, Makadia, R, Margulis, A V, Matheny, M E, Mehta, P, Morales, D R, Morgan-Stewart, H, Mosseveld, M, Newby, D, Nyberg, F, Ostropolets, A, Park, R W, Prats-Uribe, A, Rao, G A, Reich, C, Reps, J, Rijnbeek, P, Sathappan, S M K, Schuemie, M, Seager, S, Sena, A G, Shoaibi, A & OHDSI-COVID-19 consortium 2020, ' Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis : a multinational, retrospective study ', The Lancet Rheumatology, vol. 2, no. 11, pp. e698-e711 . https://doi.org/10.1016/S2665-9913(20)30276-9
Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients with COVID-19 pneumonia. We st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecc5aaf0d9ffcdac545dd4b415fc101b
https://pure.eur.nl/en/publications/03a64645-38a1-4c6c-bcd1-61d2123a4086
https://pure.eur.nl/en/publications/03a64645-38a1-4c6c-bcd1-61d2123a4086
Autor:
Solène Grosdidier, Peter Egger, Paul Avillach, Alejo J. Nevado-Holgado, Gayan Perera, Peter R. Rijnbeek, Lars Pedersen, Jana Podhorna, David Ansell, Danielle Newby, Myriam Alexander, Mees Mosseveld, Johan van der Lei, Robert Stewart, Glen James, Simon Lovestone, Daniel Prieto-Alhambra, Talita Duarte-Salles
Publikováno v:
Alzheimers Research & Therapy, 12(1):38. BioMed Central Ltd.
Newby, D, Prieto-Alhambra, D, Duarte-Salles, T, Ansell, D, Pedersen, L, Van Der Lei, J, Mosseveld, M, Rijnbeek, P, James, G, Alexander, M, Egger, P, Podhorna, J, Stewart, R, Perera, G, Avillach, P, Grosdidier, S, Lovestone, S & Nevado-Holgado, A J 2020, ' Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis : A multi-national multi-database case-control study ', Alzheimer's Research and Therapy, vol. 12, no. 1, 38 . https://doi.org/10.1186/s13195-020-00606-5
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2020)
Alzheimer's Research & Therapy
Newby, D, Prieto-Alhambra, D, Duarte-Salles, T, Ansell, D, Pedersen, L, Van Der Lei, J, Mosseveld, M, Rijnbeek, P, James, G, Alexander, M, Egger, P, Podhorna, J, Stewart, R, Perera, G, Avillach, P, Grosdidier, S, Lovestone, S & Nevado-Holgado, A J 2020, ' Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis : A multi-national multi-database case-control study ', Alzheimer's Research and Therapy, vol. 12, no. 1, 38 . https://doi.org/10.1186/s13195-020-00606-5
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2020)
Alzheimer's Research & Therapy
Background Inflammatory processes have been shown to play a role in dementia. To understand this role, we selected two anti-inflammatory drugs (methotrexate and sulfasalazine) to study their association with dementia risk. Methods A retrospective mat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1f0a76e52f0541047725123b124370
https://doi.org/10.21203/rs.2.17378/v1
https://doi.org/10.21203/rs.2.17378/v1
Autor:
Nigel K Arden, Edward Burn, Rafael Pinedo-Villanueva, Christopher J Edwards, Cyrus Cooper, Daniel Prieto-Alhambra, David W. Murray, Alan J. Silman
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Rheumatology (Oxford, England)
Universitat Autònoma de Barcelona
Rheumatology (Oxford, England)
Objective To estimate the lifetime risk of knee and hip replacement following a diagnosis of RA. Methods The analysis was undertaken using routinely collected data from the English NHS. Diagnosis of RA was identified using primary care records, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a6e419ab8ace477be09992ebf3f2c1c
https://ddd.uab.cat/record/223655
https://ddd.uab.cat/record/223655
Autor:
David W. Murray, Edward Burn, Rafael Pinedo-Villanueva, Alan J. Silman, Daniel Prieto-Alhambra, Christopher J Edwards, Cyrus Cooper, Nigel K Arden
Publikováno v:
Clinical Epidemiology
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Clinical Epidemiology, Vol Volume 10, Pp 697-704 (2018)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Clinical Epidemiology, Vol Volume 10, Pp 697-704 (2018)
Edward Burn,1 Christopher J Edwards,2 David W Murray,1 Alan Silman,1 Cyrus Cooper,1,3 Nigel K Arden,1,3 Daniel Prieto-Alhambra,1,4 Rafael Pinedo-Villanueva1,3 1Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University
Autor:
Sergio Fernandez Bertolin, Anthony G. Sena, Albert Prats-Uribe, Thomas Falconer, Osaid Alser, Kristine E. Lynch, Vignesh Subbian, Evan P. Minty, Eng Hooi Tan, Daniel Prieto-Alhambra, Clair Blacketer, Jose D. Posada, Dalia Dawoud, Yue Yang, Thamir M. Alshammari, Scott L. DuVall, Michael E. Matheny, Christian G. Reich, David Vizcaya, Aaron Abend, Lana Yh Lai, Heba Alghoul, Anna Ostropolets, Lin Zhang, Karishma Shah, Carlos Areia, Peter R. Rijnbeek, Matthew E. Spotnitz, Nigam H. Shah, Paula Casajust, Arani Vivekanantham, Patrick B. Ryan, Karthik Natarajan, Jitendra Jonnagaddala, Daniel R. Morales, Talita Duarte-Salles, Fredrik Nyberg, Kristin Kostka, Marc A. Suchard, George Hripcsak, Waheed-Ul-Rahman Ahmed, Jennifer C E Lane, Martina Recalde, Seng Chan You, Mengchun Gong, Asieh Golozar
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
ObjectivePatients with autoimmune diseases were advised to shield to avoid COVID-19, but information on their prognosis is lacking. We characterised 30-day outcomes and mortality after hospitalisation with COVID-19 among patients with prevalent autoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a79ff42720479a50b08158b7940c18